Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2015 June;40(2) > Minerva Endocrinologica 2015 June;40(2):105-18


A Journal on Endocrine System Diseases

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118




Minerva Endocrinologica 2015 June;40(2):105-18

language: English

Fertility preservation in cancer survivors

Winkler-Crepaz K. 1, Ayuandari S. 1, 2, Ziehr S. C. 1, 3, Hofer S. 1, Wildt L. 1

1 Department of Gynecological, Endocrinology and Reproductive Medicine, Innsbruck Medical University, Innsbruck, Austria;
2 Department of Obstetrics and Gynecology, Gadjah Mada University, Yogyakarta, Indonesia;
3 A.R.T. Bogenhausen, Munich, Germany


Due to the increasing number of long-term cancer survivors, physicians of all specialties are confronted with the need to prevent side effects of the applied oncologic treatments. In the field of reproductive medicine fertility preservation has gained importance as most oncologic treatments have detrimental immediate or long-term impacts on male and female fertility. The American Society of Clinical Oncology and the American Society for Reproductive Medicine, as well as the recently founded International Society for Fertility Preservation propose several established and investigational options for fertility preservation. This review aims to summarize currently available techniques for fertility preservation and future perspectives in this field, as well as to provide recommendations for patient follow-up after cancer and during pregnancy.

top of page